CHICAGO (AP) 鈥� CHICAGO (AP) 鈥� Xeris Biopharma Holdings, Inc. (XERS) on Thursday reported a loss of $31.1 million in its second quarter.
The Chicago-based company said it had a loss of 18 cents per share. Earnings, adjusted to extinguish debt, came to less than 1 cent on a per-share basis.
The average estimate of three analysts surveyed by Zacks Investment Research was for earnings of 2 cents per share.
The company posted revenue of $92.1 million in the period, surpassing Street forecasts. Three analysts surveyed by Zacks expected $90.7 million.
Xeris Biopharma expects full-year revenue in the range of $385 million to $390 million.
_____
This story was generated by (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a at https://www.zacks.com/ap/XERS
Copyright © 2026 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
